Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGM | P11217 | 3/20 | 0.60 |
| ▸ | TK2 | O00142 | 2/20 | 0.58 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.51 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.51 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.51 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.51 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.47 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MTOR | P42345 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.41 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.41 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13518430 | 0.96 | PYGM (0.55) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL1140106 | 0.88 | PYGM (0.61) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL6829043 | 0.85 | PYGM (0.63) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL3420804 | 0.83 | PYGM (0.61) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL10645083 | 0.82 | PYGM (0.66) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL10644978 | 0.82 | PYGM (0.66) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL10644984 | 0.82 | PYGM (0.66) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL6758892 | 0.82 | PYGM (0.66) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL2582684 | 0.82 | PYGM (0.66) | PYGMTK2SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL8369203 | 0.81 | PYGM (0.65) | PYGMTK2SLC28A1SLC28A2SLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3229 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109727-A1 | RNA CONSTRUCTS AND USES THEREOF | BioNTech SE (DE) | 2026-04-23 | — | — | US | claimed |
| EP-4720279-A2 | CIS-REGULATORY ELEMENTS OF TRANSLATION AND METHODS USING SAME | Yale University (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4716748-A2 | METHOD OF MODULATING MRNA TRANSLATION | Yale University (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4696703-A2 | NUCLEIC ACID MOLECULES AND USES THEREOF | CureVac SE (DE) | 2026-02-18 | — | — | EP | claimed |
| EP-4665405-A1 | DNA COMPOSITIONS COMPRISING MODIFIED URACIL | Flagship Pioneering Innovations VII, LLC (US) | 2025-12-24 | — | — | EP | claimed |
| US-20250340868-A1 | POLYNUCLEOTIDES ENCODING LINKED ANTIGENS AND USES THEREOF | STEMCELL TECHNOLOGIES CANADA INC (CA) | 2025-11-06 | — | — | US | claimed |
| EP-4634380-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4631970-A2 | NUCLEIC ACID MOLECULES AND USES THEREOF | CureVac SE (DE) | 2025-10-15 | — | — | EP | claimed |
| US-20250295744-A1 | TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN VACCINATION AND PD-1 AXIS BINDING ANTAGONISTS | BioNTech SE (DE) | 2025-09-25 | — | — | US | claimed |
| US-20250277223-A1 | METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISEASES | IMCYSE SA (BE) | 2025-09-04 | — | — | US | claimed |
| US-20110269820-A1 | SPINAL MUSCULAR ATROPHY TREATMENT VIA TARGETING SMN2 CATALYTIC CORE | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2011-11-03 | — | — | US | claimed |
| US-7838657-B2 | compositions capable of blocking the inhibitory effect of a newly-identified intronic inhibitory sequence element, named ISS-N1 (intronic splicing silencer), located in the SMN2 gene | UNIVERSITY OF MASSACHUSETTS (US) | 2010-11-23 | — | — | US | claimed |
| US-20100087511-A1 | SPINAL MUSCULAR ATROPHY (SMA) TREATMENT VIA TARGETING OF SMN2 SPLICE SITE INHIBITORY SEQUENCES | UNIVERSITY OF MASSACHUSETTS (US) | 2010-04-08 | — | — | US | claimed |
| US-20080311040-A1 | METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA | FLAGSHIP VENTURES (US) | 2008-12-18 | — | — | US | claimed |
| WO-2008109105-A2 | METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH SIRNA | FLAGSHIP VENTURES (US) | 2008-09-12 | — | — | WO | claimed |
| US-20070292408-A1 | Spinal Muscular Atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences | UNIVERSITY OF MASSACHUSETTS (US) | 2007-12-20 | — | — | US | claimed |
| EP-1556402-A4 | IN VIVO GENE SILENCING BY CHEMICALLY MODIFIED AND STABLE SIRNA | UNIV MASSACHUSETTS (US) | 2007-10-10 | — | — | EP | claimed |
| EP-1556402-A2 | IN VIVO GENE SILENCING BY CHEMICALLY MODIFIED AND STABLE SIRNA | University of Massachusetts (US) | 2005-07-27 | — | — | EP | claimed |
| US-20050020521-A1 | Rna interference strands and antibody strands | UNIVERSITY OF MASSACHUSETTS (US) | 2005-01-27 | — | — | US | claimed |
| WO-2004029212-A2 | IN VIVO GENE SILENCING BY CHEMICALLY MODIFIED AND STABLE SIRNA | UNIVERSITY OF MASSACHUSETTS (US) | 2004-04-08 | — | — | WO | claimed |